BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9712854)

  • 1. NH2-terminal structural motifs in staphylokinase required for plasminogen activation.
    Schlott B; Gührs KH; Hartmann M; Röcker A; Collen D
    J Biol Chem; 1998 Aug; 273(35):22346-50. PubMed ID: 9712854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylokinase requires NH2-terminal proteolysis for plasminogen activation.
    Schlott B; Gührs KH; Hartmann M; Röcker A; Collen D
    J Biol Chem; 1997 Feb; 272(9):6067-72. PubMed ID: 9038231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the N-terminal region of staphylokinase (SAK): evidence for the participation of the N-terminal region of SAK in the enzyme-substrate complex formation.
    Rajamohan G; Dikshit KL
    FEBS Lett; 2000 Jun; 474(2-3):151-8. PubMed ID: 10838076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine 719 in human plasminogen mediates formation of the staphylokinase:plasmin activator complex.
    Jespers L; Van Herzeele N; Lijnen HR; Van Hoef B; De Maeyer M; Collen D; Lasters I
    Biochemistry; 1998 May; 37(18):6380-6. PubMed ID: 9572854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26.
    Schlott B; Hartmann M; Gührs KH; Birch-Hirschfeld E; Gase A; Vettermann S; Collen D; Lijnen HR
    Biochim Biophys Acta; 1994 Feb; 1204(2):235-42. PubMed ID: 8142464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of the 90-loop (Thr90-Glu100) region of staphylokinase in plasminogen activation probed through site-directed mutagenesis and loop deletion.
    Rajamohan G; Dahiya M; Mande SC; Dikshit KL
    Biochem J; 2002 Jul; 365(Pt 2):379-89. PubMed ID: 11936951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional significance of NH2- and COOH-terminal regions of staphylokinase in plasminogen activation.
    Gase A; Hartmann M; Gührs KH; Röcker A; Collen D; Behnke D; Schlott B
    Thromb Haemost; 1996 Nov; 76(5):755-60. PubMed ID: 8950786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of staphylokinase concentration of plasminogen activation.
    Arai K; Mimuro J; Madoiwa S; Matsuda M; Sako T; Sakata Y
    Biochim Biophys Acta; 1995 Aug; 1245(1):69-75. PubMed ID: 7654768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the interaction between plasminogen and staphylokinase.
    Lijnen HR; De Cock F; Van Hoef B; Schlott B; Collen D
    Eur J Biochem; 1994 Aug; 224(1):143-9. PubMed ID: 8076635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylokinase as a plasminogen activator component in recombinant fusion proteins.
    Szarka SJ; Sihota EG; Habibi HR; Wong S
    Appl Environ Microbiol; 1999 Feb; 65(2):506-13. PubMed ID: 9925575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex.
    Shibata H; Nagaoka M; Sakai M; Sawada H; Watanabe T; Yokokura T
    J Biochem; 1994 Apr; 115(4):738-42. PubMed ID: 8089091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the kringle domain in plasminogen activation with staphylokinase.
    Arai K; Madoiwa S; Mimuro J; Asakura S; Matsuda M; Sako T; Sakata Y
    J Biochem; 1998 Jan; 123(1):71-7. PubMed ID: 9504411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of staphylokinase-derived nonadecapeptide on the activation of plasminogen.
    Okada K; Ueshima S; Matsuno H; Kawao N; Okamoto C; Tanaka M; Matsuo O
    Thromb Haemost; 2007 May; 97(5):795-802. PubMed ID: 17479190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel recombinant thrombolytic and antithrombotic staphylokinase variants with an RGD motif at their N-termini.
    He J; Di J; Xu R; Zhao B
    Biotechnol Appl Biochem; 2008 May; 50(Pt 1):17-23. PubMed ID: 18039183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular conversions of recombinant staphylokinase during plasminogen activation in purified systems and in human plasma.
    Ueshima S; Silence K; Collen D; Lijnen HR
    Thromb Haemost; 1993 Sep; 70(3):495-9. PubMed ID: 8259556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional basis of plasminogen activation by staphylokinase.
    Jespers L; Vanwetswinkel S; Lijnen HR; Van Herzeele N; Van Hoef B; Demarsin E; Collen D; De Maeyer M
    Thromb Haemost; 1999 Apr; 81(4):479-85. PubMed ID: 10235424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human plasminogen by staphylokinase. Direct evidence that preformed plasmin is necessary for activation to occur.
    Grella DK; Castellino FJ
    Blood; 1997 Mar; 89(5):1585-9. PubMed ID: 9057640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex.
    Okada K; Nonaka T; Matsumoto H; Fukao H; Ueshima S; Matsuo O
    Thromb Res; 1994 Oct; 76(2):211-20. PubMed ID: 7863470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of the bacterial plasminogen activator staphylokinase secreted by a recombinant Bacillus subtilis.
    Gerlach D; Kraft R; Behnke D
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):314-22. PubMed ID: 3146168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function relationships in staphylokinase as revealed by "clustered charge to alanine" mutagenesis.
    Silence K; Hartmann M; Gührs KH; Gase A; Schlott B; Collen D; Lijnen HR
    J Biol Chem; 1995 Nov; 270(45):27192-8. PubMed ID: 7592976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.